Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia

NCT04720534 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

229

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Hypertriglyceridemia

Interventions

DRUG: ARO-APOC3
DRUG: Placebo

Sponsor

Arrowhead Pharmaceuticals